Concordance Between ETCO2, PTCO2 and PaCO2 in the Home-ventilated Neuromuscular Patient

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

28 participants

Study Classification

OBSERVATIONAL

Study Start Date

2014-04-30

Study Completion Date

2015-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare the measure of the CO2 obtained on the end-tidal expiratory gas (ETCO2) with the value of CO2 obtained by transcutaneous measure (PTCO2), in home-ventilated neuromuscular patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Prognostic Value of Residual Hypoventilation in Mechanically Ventilated Neuromuscular Patients

NCT02551406

Home Mechanical Ventilation Neuromuscular Disease

COMPLETED

Installation of Non-invasive Ventilation at Home Using Telemedicine : a Pilot Study on Feasibility and Impact on Ventilation Compliance

NCT02103790

Neuromuscular Diseases Kyphoscoliosis Non Invasive Ventilation

UNKNOWN NA

Monitoring of Patients With Chronic Respiratory Failure Treated With Non-invasive Home Ventilation: Contribution of New Monitoring Tools

NCT04872062

Chronic Hypercapnic Respiratory Failure

UNKNOWN

Validation Of Tidal/End -Tidal CO2 in ALS

NCT03764384

Motor Neuron Disease Amyotrophic Lateral Sclerosis

UNKNOWN

Comparison of a Hyperinflation Mode and Air Stacking on Neuromuscular Patients Under Volumetric Ventilation

NCT02847299

Neuromuscular Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Monitoring of the effectiveness of ventilation in patients with neuromuscular require to regularly measure blood gases and in particular carbon dioxide (CO2). The reference technique is arterial puncture. In recent years, a non-invasive techniques measuring CO2 by transcutaneous sensor (PTCO2) was introduced among the tools regularly used for follow-up monitoring of home ventilated patients.

Another technique for monitoring CO2, originally developed for anesthesia, is based on the measurement of exhaled CO2 (ETCO2). This technique requires relatively simple equipment, and represents a potential alternative for monitoring home-ventilated patients.

Recently, sensors for ETCO2 were coupled to devices for home ventilation. To the best of our knowledge, the role of ETCO2 in monitoring long-term ventilated patients has not been investigated to date.

The purpose of the study is to analyze the correlation between the two non-invasive methods for measuring CO2: PTCO2 and ETCO2, in a group of home-ventilated patients with neuromuscular disease.

The patients will be recruited during a routine follow-up hospitalization for their home-ventilation, and the ETCO2 will be measured during one night, in addition to the routinely measured PTCO2.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Neuromuscular Disease Chronic Respiratory Insufficiency Intermittent Positive-pressure Ventilation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Monitoring of ETCO2 and PTCO2

All neuromuscular patients

Monitoring of ETCO2 and PTCO2

Intervention Type DEVICE

Concomitant monitoring of ETCO2 and PTCO2

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Monitoring of ETCO2 and PTCO2

Concomitant monitoring of ETCO2 and PTCO2

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

PTCO2: Sentec Capno-Oxymetry (Sentec) ETCO2: Module of the BREAS Vivo 50 home ventilator

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient with neuromuscular disease, treated with home invasive or non-invasive ventilation
* Male or female age higher or equal to 18 years
* Negative pregnancy test for women of childbearing age or having an effective contraception

Exclusion Criteria

* Acute Respiratory Failure
* Long-term oxygen therapy
* Refusal to participate in the study
* Plan of legal protection
* Pregnant Women
* Failure to cooperate
* No affiliation to a social security scheme

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No